School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Bright Minds Biosciences Inc. DRUG

Healthcare · Biotechnology

$54.01last close 2026-10-12 · market cap $532.76M · delayed data

Trailing returns

1M-14.51%
3M-30.61%
6M-35.36%
1Y-14.66%
5Y+45.58%

Basis: Adjusted daily closes.

What it does

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Open DRUG in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies